J C Fink
Overview
Explore the profile of J C Fink including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
364
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Provenzano R, Garcia-Mayol L, Suchinda P, Von Hartitzsch B, Woollen S, Zabaneh R, et al.
Clin Nephrol
. 2004 Jul;
61(6):392-405.
PMID: 15224803
Background And Aim: Anemia occurs in approximately 47% of patients with chronic kidney disease (CKD) not on dialysis. Recombinant human erythropoietin (r-HuEPO, epoetin alfa) has been proven safe and effective...
2.
Drachenberg R, Drachenberg C, Papadimitriou J, Ramos E, Fink J, Wali R, et al.
Am J Transplant
. 2002 Jul;
1(4):373-81.
PMID: 12099383
The morphological features of polyoma virus disease (PVDz) in 571 concurrent urine and biopsy samples from 413 patients are described. In 54 patients PV was found in both biopsy and...
3.
Fink J, Salmanullah M, Blahut S, Weir M, Sawyer R, Henrich W, et al.
Am J Nephrol
. 2001 Oct;
21(5):386-9.
PMID: 11684800
Unlabelled: Although it is anticipated that most patients with renal insufficiency will progress towards end-stage renal disease (ESRD) there have been few population-based studies to validate this assumption. We examined...
4.
Weir M, Rosenberger C, Fink J
Am J Hypertens
. 2001 Oct;
14(9 Pt 1):963-8.
PMID: 11587165
Combination therapy is required in many patients to achieve goal blood pressure (BP). Calcium antagonists are highly effective antihypertensive drugs in a broad range of demographic groups. Yet, higher doses...
5.
Fink J, Henrich W
Semin Nephrol
. 2001 Jul;
21(4):356-61.
PMID: 11455523
Caring for the urban renal patient can be a challenge to providers for many reasons. Although racial and socioeconomic factors have an impact on the health of this population, one...
6.
Drachenberg C, Papadimitriou J, Farney A, Wiland A, Blahut S, Fink J, et al.
Transplantation
. 2001 Jul;
71(12):1784-91.
PMID: 11455259
Background: Graft losses due to leaks, bleeding, thrombosis, infections, and early pancreatitis are grouped together under the category of technical failure. Among these complications, massive vascular thrombosis continues to be...
7.
Stern J, Sullivan K, Ott S, Seidel K, Fink J, Longton G, et al.
Biol Blood Marrow Transplant
. 2001 Jun;
7(5):257-64.
PMID: 11400947
The incidence and course of bone density abnormalities following hematopoietic stem cell transplantation are poorly understood and complicated by the impact of multiple factors. Hip, spine, and wrist bone mineral...
8.
Wiland A, Fink J, Philosophe B, Farney A, Schweitzer E, Colonna J, et al.
Transplant Proc
. 2001 Mar;
33(1-2):1910.
PMID: 11267566
No abstract available.
9.
Weir M, Ward M, Blahut S, Klassen D, Cangro C, Bartlett S, et al.
Kidney Int
. 2001 Mar;
59(4):1567-73.
PMID: 11260422
Background: Chronic allograft nephropathy is the major cause of progressive renal failure in renal transplant recipients. It has no definitive treatment. Methods: One hundred eighteen renal transplant recipients with declining...
10.
Klassen D, Drachenberg C, Papadimitriou J, Cangro C, Fink J, Bartlett S, et al.
Transplantation
. 2000 Jun;
69(9):1968-71.
PMID: 10830244
Background: Cytomegalovirus (CMV) infection is a common problem in solid organ transplant recipients. CMV infection of pancreas allografts is not, however, well described. Methods: We report the clinical presentation, histologic...